D-0422-2019 Class II Terminated

Recalled by Sun Pharmaceutical Industries, Inc. — Cranbury, NJ

FDA drug recall D-0422-2019 was initiated by Sun Pharmaceutical Industries, Inc. on Jan 24, 2019 and is designated Class II. Reason for recall: Bromfenac Ophthalmic Solution, 0.075% (Sterile 5 mL) may have a lack of sterility assurance. The recall status is terminated (terminated Feb 22, 2021). Affected quantity: 69840 bottles.

Recall details

Product Type
Drugs
Report Date
Feb 6, 2019
Initiation Date
Jan 24, 2019
Termination Date
Feb 22, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
69840 bottles

Product description

BromSite (bromfenac ophthalmic solution) 0.075%, 5 mL bottles, Rx Only, Distributed by : Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, NDC 49708-754-41

Reason for recall

Bromfenac Ophthalmic Solution, 0.075% (Sterile 5 mL) may have a lack of sterility assurance.

Distribution pattern

Nationwide within the United States

Code information

Lot #: V18E01, Exp. 05/2020

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0422-2019
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0422-2019. Report a data issue: hello@regdatalab.com.